EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Direct cellular targets and anticancer mechanisms of the natural product oridonin

Jialin Yao, Lu Liu, Qingxiang Sun, Xiaofei Shen

MedComm – Future Medicine · 2023-03 · 2 (1)

DOI: 10.1002/mef2.35 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Future Medicine, online erschienen am 24.02.2023. Verfasst von Jialin Yao und 3 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu University of Traditional Chinese Medicine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is one of the leading causes of death worldwide. The proliferation, survival, and metastasis of cancer cells are governed by a complex series of intracellular and extracellular signaling pathways. Therefore, efficient cancer therapy often requires the modulation of multiple targets. Besides, the modulation of several biological targets with a single drug can lead to synergistic therapeutic effects and avoid side effects associated with combination therapy. Oridonin, an ent‐kaurane type diterpenoid isolated from Rabdosia rubescens , has been reported to possess potent anti‐inflammatory, antioxidant, anticancer, and neuroprotective activities. Among its many benefits, the anticancer effects have attracted the most attention because of its effectiveness in many tumor cells and its potential to overcome therapeutic resistance. Recently, several proteins involved in oncogenic signaling, including CRM1, PHGDH, HSP70, AML1‐ETO, and STAT3, were identified as functional targets of oridonin and its analogs. The binding mechanism and the consequence of oridonin binding to these oncogenic proteins are summarized and discussed. These advances suggest that oridonin exhibits broad spectrum anticancer effects by targeting multiple oncogenic proteins mainly via Michael addition between its unsaturated ketone and the cysteines in the target proteins. Therefore, oridonin and its derivatives hold the potential to be developed as multitargeting anticancer drugs.

Förderung

  • Chengdu University of Traditional Chinese Medicine

Zitieren

APA

Yao, J., Liu, L., Sun, Q., & Shen, X. (2023). Direct cellular targets and anticancer mechanisms of the natural product oridonin. MedComm – Future Medicine, 2(1). https://doi.org/10.1002/mef2.35

Vancouver

Yao J, Liu L, Sun Q, Shen X. Direct cellular targets and anticancer mechanisms of the natural product oridonin. MedComm – Future Medicine. 2023;2(1). doi:10.1002/mef2.35

BibTeX
@article{Yao2023,
  author = {Yao, Jialin and Liu, Lu and Sun, Qingxiang and Shen, Xiaofei},
  title = {Direct cellular targets and anticancer mechanisms of the natural product oridonin},
  journal = {MedComm – Future Medicine},
  year = {2023},
  volume = {2},
  number = {1},
  doi = {10.1002/mef2.35}
}
Kostenlos starten →